Machine Learning and Radiomics in Nuclear Medicine and Molecular imaging: Part II.

Khalil, Magdy M.

doi:10.21608/egyjnm.2021.217667

Machine Learning and Radiomics in Nuclear Medicine and Molecular imaging: Part II.

Document Type : Editorial

Author

Magdy M. Khalil ¹^{, 2}

¹ School of Biotechnology, Badr University. +

² Medical Biophysics, Department of Physics, Faculty of Science, Helwan University, Cairo, Egypt.

10.21608/egyjnm.2021.217667

Abstract

Diagnostic imaging modalities are undergoing a paradigm shift in technological advances and this has significantly impacted patient diagnosis and treatment. The introduction of machine learning and Radiomics in data analysis with capabilities of creating new clinical models has recently caught the attention of clinicians and scientists. Radiomics is a high throughput technology able to derive many imaging features from the diagnostic data while machine learning is a computer science discipline able to provide new forms of “electronic observer” able to mimic human tasks performed by radiologists and nuclear medicine physicians in daily routines. These technologies could be used individually or in combination to facilitate as well as solving issues associated with initial patient diagnosis, image processing, data analysis, stratification, prognosis and management. In the last decade, there was a rapidly growing interest in using Radiomics in nuclear medicine and molecular imaging providing several solutions in reducing the injected radio activities, reducing imaging time, lesion segmentation, diagnosis, and many other applications that could potentially serve or replace current practices. The goal of this part of the machine learning and Radiomics in nuclear medicine series is to introduce the reader to these new technologies and open avenues on current status, potential and future promises.

Keywords